Question 63

Buprenorphine requires the prescriber's DEA number on a prescription according to federal law.

In accordance with federal regulations, the prescriber's DEA number must be included on a prescription for buprenorphine due to its classification as a controlled substance.

A) bupropion

Bupropion is not classified as a controlled substance, thus it does not require a DEA number on its prescription. While it is a prescription medication, it falls outside the federal regulations concerning controlled substances.

B) buspirone

Buspirone is also not categorized as a controlled substance; therefore, a DEA number is not necessary for its prescription. This medication is primarily used for anxiety and is regulated differently from controlled substances.

C) bumetanide

Bumetanide is a loop diuretic used to treat edema and is not classified as a controlled substance. Consequently, prescriptions for bumetanide do not need to include a DEA number.

D) buprenorphine

Buprenorphine is classified as a Schedule III controlled substance, which mandates that the prescriber's DEA number must be included on prescriptions. This requirement is in place to monitor and control the prescribing of medications that have potential for abuse.

Conclusion

Buprenorphine is the only option listed that requires the prescriber’s DEA number on a prescription due to its status as a controlled substance. All other options—bupropion, buspirone, and bumetanide—are not classified in this way, which is why they do not necessitate a DEA number. This distinction highlights the importance of regulatory compliance in the prescription of controlled substances.